BioSpace News Archive

Evaxion Biotech A/S, a clinical-stage biotechnology company specializing in the discovery and development of AI-powered immunotherapies, announced that it will hold an R&D Day at 12:30 p.m CEST on May 25, 2023.

Locanabio, Inc. announced the presentation of data from its lead vectorized snRNA exon skipping program, LBIO-115, in development for the treatment of Duchenne muscular dystrophy.

IDEAYA Biosciences, Inc. announced that it has amended its clinical trial collaboration and supply agreements with Pfizer Inc. to support evaluation of darovasertib and crizotinib combination therapy in the company’s planned Phase 2/3 registrational clinical trial in MUM and to continue support of the company’s ongoing Phase 2 clinical trial in MUM.

Cimeio Therapeutics, a biotechnology company developing a novel approach to cell therapies, presented data for its CD45 Shielded Cell & Immunotherapy Pair program at the American Society of Gene and Cell Therapy’s Annual Meeting in Los Angeles.

Affimed N.V., a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced that it will release first quarter 2023 results and corporate update on Tuesday, May 23, 2023.

Caris Life Sciences® announced that Robert H. Lurie Comprehensive Cancer Center of Northwestern University has joined the Caris Precision Oncology Alliance™.

BD (Becton, Dickinson and Company) today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the new BD Kiestra™ Methicillin-resistant Staphylococcus aureus (MRSA) imaging application that uses artificial intelligence (AI) to interpret bacterial growth and release negative specimens with minimal human interaction.

Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities announced the expansion of the Advanced Cell Diagnostics -branded RNAscope™ in situ hybridization portfolio with the release of a RNAscope multiomic workflow for the Standard BioTools Hyperion™ Imaging System.

Labcorp, a leading global life sciences company, announced it entered into an agreement with Providence to expand the longstanding strategic relationship between the two organizations.

Terray Therapeutics today announced the appointment of Sudha Parasuraman, MD, as an Independent Director.